In the cited meta-analysis, colchicine was associated with reduced risk of treatment failure (OR: 0.23) and recurrent pericarditis (OR: 0.39), but with a trend toward more adverse effects. [34 ...

Expert Rev Anti Infect Ther. 2011;9(9):787-802.